Skip to content

Efavirenz, Kaletra and boosted atazanavir reduce levels of key anti-malaria drug

Drug-resistant TB now at record levels, says WHO

Weight gain after starting ART predicts survival

'Test and treat' prevention approach may not require universal treatment to succeed

Pressure growing on wealthy nations for clear signal on long-term funds for HIV

Hospital admissions remain high amongst those with HIV

South Africa: Delayed drug registrations hard to swallow

International AIDS Society launches HIV research agenda for women and children

Beliefs about reduced infection risk on ART linked to STI risk